A permament crystallography team leader position is being advertised at the AstraZeneca research site in Boston, USA. The job involves structure-based drug design support for local infection and oncology activities, and supervising a new team of two highly talented crystallographers. The team leader will report to me at Alderley Park, UK. In honesty, I should warn that it is becoming increasingly difficult to get these positions unless you have some kind of permanent residence status in the US, otherwise there is the usual requirement to demonstrate that there are no suitably qualified US candidates, which in our field is generally a non-starter.
We're looking for someone with significant post- PhD experience, broad scientific credibility, previous drug design, industrial or high throughput experience would be valuable, previous people responsibilities would be valuable, and we'd be looking for good interpersonal, communication and networking skills. If you're interested, you need to submit a cv via the career links in AstraZeneca web pages. You can visit www.astrazeneca-us.com, or www.astrazeneca.com and navigate to jobs in the USA. Please enter 1787433 in the requisition number field to locate this position. Many thanks, Richard Pauptit Associate Director and Principal Scientist Cell, Protein, & Structural Sciences AstraZeneca 50S36, Mereside, Alderley Park Macclesfield SK10 4TG Cheshire, UK. email: [email protected] tel: +44 1625 516135 -------------------------------------------------------------------------- AstraZeneca UK Limited is a company incorporated in England and Wales with registered number: 03674842 and a registered office at 15 Stanhope Gate, London W1K 1LN. Confidentiality Notice: This message is private and may contain confidential, proprietary and legally privileged information. If you have received this message in error, please notify us and remove it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorised use or disclosure of the contents of this message is not permitted and may be unlawful. Disclaimer: Email messages may be subject to delays, interception, non-delivery and unauthorised alterations. Therefore, information expressed in this message is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by an authorised representative independent of this message. No contractual relationship is created by this message by any person unless specifically indicated by agreement in writing other than email. Monitoring: AstraZeneca UK Limited may monitor email traffic data and content for the purposes of the prevention and detection of crime, ensuring the security of our computer systems and checking Compliance with our Code of Conduct and Policies.
